🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/07/2006 | 35,31 | 35,63 | 34,87 | 35,56 | +1,22% | 2,16% | 9.632.692 |
| 10/07/2006 | 35,31 | 35,58 | 35,13 | 35,13 | -0,41% | 1,27% | 8.889.870 |
| 07/07/2006 | 35,02 | 35,31 | 34,68 | 35,28 | +0,85% | 1,80% | 10.487.126 |
| 06/07/2006 | 35,02 | 35,26 | 34,83 | 34,98 | -0,08% | 1,23% | 10.166.019 |
| 05/07/2006 | 34,96 | 35,22 | 34,84 | 35,01 | +0,19% | 1,09% | 9.021.813 |
| 03/07/2006 | 35,21 | 35,24 | 34,79 | 34,94 | +0,52% | 1,27% | 9.162.664 |
| 30/06/2006 | 34,42 | 35,15 | 34,36 | 34,76 | +1,50% | 2,30% | 13.449.613 |
| 29/06/2006 | 33,57 | 34,35 | 33,54 | 34,25 | +2,25% | 2,42% | 10.738.437 |
| 28/06/2006 | 33,39 | 33,73 | 33,32 | 33,49 | +1,12% | 1,23% | 8.674.715 |
| 27/06/2006 | 33,30 | 33,38 | 33,02 | 33,12 | -0,89% | 1,06% | 6.566.034 |
| 26/06/2006 | 33,49 | 33,84 | 33,11 | 33,42 | +0,23% | 2,17% | 8.081.757 |
| 23/06/2006 | 33,44 | 33,46 | 33,12 | 33,34 | -0,88% | 1,03% | 7.511.016 |
| 22/06/2006 | 33,57 | 34,02 | 33,44 | 33,64 | -0,06% | 1,71% | 9.496.033 |
| 21/06/2006 | 33,32 | 33,83 | 33,29 | 33,65 | +1,00% | 1,60% | 8.932.628 |
| 20/06/2006 | 33,03 | 33,42 | 32,92 | 33,32 | +1,33% | 1,50% | 9.657.425 |
| 19/06/2006 | 32,91 | 33,18 | 32,82 | 32,88 | +0,15% | 1,07% | 8.743.150 |
| 16/06/2006 | 32,82 | 33,16 | 32,53 | 32,83 | +0,23% | 1,92% | 9.958.830 |
| 15/06/2006 | 32,02 | 32,85 | 31,93 | 32,76 | +2,51% | 2,89% | 10.988.909 |
| 14/06/2006 | 32,02 | 32,19 | 31,60 | 31,96 | -0,51% | 1,85% | 7.433.883 |
| 13/06/2006 | 32,07 | 32,51 | 31,64 | 32,12 | +0,87% | 2,71% | 11.312.007 |
| 12/06/2006 | 32,50 | 32,57 | 31,83 | 31,84 | -1,30% | 2,26% | 6.864.714 |
| 09/06/2006 | 32,44 | 32,59 | 32,21 | 32,26 | -0,47% | 1,15% | 7.848.158 |
| 08/06/2006 | 32,37 | 32,96 | 31,93 | 32,41 | +0,03% | 3,18% | 14.839.366 |
| 07/06/2006 | 32,52 | 32,93 | 32,39 | 32,40 | +0,18% | 1,67% | 9.260.757 |
| 06/06/2006 | 32,16 | 32,40 | 31,87 | 32,35 | +1,28% | 1,63% | 8.809.698 |
| 05/06/2006 | 32,30 | 32,47 | 31,88 | 31,94 | -1,41% | 1,83% | 5.448.133 |
| 02/06/2006 | 32,11 | 32,67 | 31,97 | 32,40 | +0,44% | 2,20% | 6.995.924 |
| 01/06/2006 | 31,98 | 32,27 | 31,83 | 32,25 | +1,53% | 1,37% | 13.139.510 |
| 31/05/2006 | 31,50 | 31,81 | 31,25 | 31,77 | +0,45% | 1,79% | 13.282.457 |
| 30/05/2006 | 32,74 | 33,04 | 31,62 | 31,62 | -4,11% | 4,34% | 17.535.974 |